CAR T cell therapy for meningioma : mesothelin emerges as a novel promising target

Migliorini, Denis

doi:10.1093/neuonc/noaf240

Scientific article

English

CAR T cell therapy for meningioma : mesothelin emerges as a novel promising target

ContributorsMigliorini, Denis

Published inNeuro-oncology, noaf240

First online date2025-10-11

UNIGE affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

UNIGE research groups

Tumeurs cérébrales (1016)

Citation (ISO format)

MIGLIORINI, Denis. CAR T cell therapy for meningioma : mesothelin emerges as a novel promising target. In: Neuro-oncology, 2025, p. noaf240. doi: 10.1093/neuonc/noaf240

Article (Accepted version)

Identifiers

PID : unige:189180
DOI : 10.1093/neuonc/noaf240
PMID : 41075169

Additional URL for this publicationhttps://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf240/8283559

Journal ISSN1522-8517

38views

0downloads

Creation16/10/2025 09:30:20

First validation26/11/2025 10:43:10

Update26/11/2025 10:43:10

Status update26/11/2025 10:43:10

Last indexation14/10/2026 00:17:03

Archive ouverte UNIGE

CAR T cell therapy for meningioma : mesothelin emerges as a novel promising target

Technical informations